These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 32718943)
1. Effect of Low-dose and Standard-dose Aspirin on PGE Drew DA; Schuck MM; Magicheva-Gupta MV; Stewart KO; Gilpin KK; Miller P; Parziale MP; Pond EN; Takacsi-Nagy O; Zerjav DC; Chin SM; Mackinnon Krems J; Meixell D; Joshi AD; Ma W; Colizzo FP; Carolan PJ; Nishioka NS; Staller K; Richter JM; Khalili H; Gala MK; Garber JJ; Chung DC; Yarze JC; Zukerberg L; Petrucci G; Rocca B; Patrono C; Milne GL; Wang M; Chan AT Cancer Prev Res (Phila); 2020 Oct; 13(10):877-888. PubMed ID: 32718943 [TBL] [Abstract][Full Text] [Related]
2. ASPirin Intervention for the REDuction of colorectal cancer risk (ASPIRED): a study protocol for a randomized controlled trial. Drew DA; Chin SM; Gilpin KK; Parziale M; Pond E; Schuck MM; Stewart K; Flagg M; Rawlings CA; Backman V; Carolan PJ; Chung DC; Colizzo FP; Freedman M; Gala M; Garber JJ; Huttenhower C; Kedrin D; Khalili H; Kwon DS; Markowitz SD; Milne GL; Nishioka NS; Richter JM; Roy HK; Staller K; Wang M; Chan AT Trials; 2017 Feb; 18(1):50. PubMed ID: 28143522 [TBL] [Abstract][Full Text] [Related]
3. A randomized controlled trial of eicosapentaenoic acid and/or aspirin for colorectal adenoma prevention during colonoscopic surveillance in the NHS Bowel Cancer Screening Programme (The seAFOod Polyp Prevention Trial): study protocol for a randomized controlled trial. Hull MA; Sandell AC; Montgomery AA; Logan RF; Clifford GM; Rees CJ; Loadman PM; Whitham D Trials; 2013 Jul; 14():237. PubMed ID: 23895505 [TBL] [Abstract][Full Text] [Related]
4. Efficacy of Difluoromethylornithine and Aspirin for Treatment of Adenomas and Aberrant Crypt Foci in Patients with Prior Advanced Colorectal Neoplasms. Sinicrope FA; Velamala PR; Song LMWK; Viggiano TR; Bruining DH; Rajan E; Gostout CJ; Kraichely RE; Buttar NS; Schroeder KW; Kisiel JB; Larson MV; Sweetser SR; Sedlack RR; Sinicrope SN; Richmond E; Umar A; Della'Zanna G; Noaeill JS; Meyers JP; Foster NR Cancer Prev Res (Phila); 2019 Nov; 12(11):821-830. PubMed ID: 31484660 [TBL] [Abstract][Full Text] [Related]
5. Urinary metabolites of prostanoids and risk of recurrent colorectal adenomas in the Aspirin/Folate Polyp Prevention Study (AFPPS). Fedirko V; Bradshaw PT; Figueiredo JC; Sandler RS; Barry EL; Ahnen DJ; Milne GL; Bresalier RS; Baron JA Cancer Prev Res (Phila); 2015 Nov; 8(11):1061-8. PubMed ID: 26304466 [TBL] [Abstract][Full Text] [Related]
6. Chemoprevention of colorectal cancer: systematic review and economic evaluation. Cooper K; Squires H; Carroll C; Papaioannou D; Booth A; Logan RF; Maguire C; Hind D; Tappenden P Health Technol Assess; 2010 Jun; 14(32):1-206. PubMed ID: 20594533 [TBL] [Abstract][Full Text] [Related]
7. Metabolomics Analysis of Aspirin's Effects in Human Colon Tissue and Associations with Adenoma Risk. Barry EL; Fedirko V; Uppal K; Ma C; Liu K; Mott LA; Peacock JL; Passarelli MN; Baron JA; Jones DP Cancer Prev Res (Phila); 2020 Oct; 13(10):863-876. PubMed ID: 32655007 [TBL] [Abstract][Full Text] [Related]
8. Urinary PGE-M levels are associated with risk of colorectal adenomas and chemopreventive response to anti-inflammatory drugs. Bezawada N; Song M; Wu K; Mehta RS; Milne GL; Ogino S; Fuchs CS; Giovannucci EL; Chan AT Cancer Prev Res (Phila); 2014 Jul; 7(7):758-65. PubMed ID: 24824037 [TBL] [Abstract][Full Text] [Related]
9. Aspirin and folic acid for the prevention of recurrent colorectal adenomas. Logan RF; Grainge MJ; Shepherd VC; Armitage NC; Muir KR; Gastroenterology; 2008 Jan; 134(1):29-38. PubMed ID: 18022173 [TBL] [Abstract][Full Text] [Related]
10. A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer. Sandler RS; Halabi S; Baron JA; Budinger S; Paskett E; Keresztes R; Petrelli N; Pipas JM; Karp DD; Loprinzi CL; Steinbach G; Schilsky R N Engl J Med; 2003 Mar; 348(10):883-90. PubMed ID: 12621132 [TBL] [Abstract][Full Text] [Related]
11. A dose-finding study of aspirin for chemoprevention utilizing rectal mucosal prostaglandin E(2) levels as a biomarker. Sample D; Wargovich M; Fischer SM; Inamdar N; Schwartz P; Wang X; Do KA; Sinicrope FA Cancer Epidemiol Biomarkers Prev; 2002 Mar; 11(3):275-9. PubMed ID: 11895877 [TBL] [Abstract][Full Text] [Related]
12. Eicosapentaenoic acid and aspirin, alone and in combination, for the prevention of colorectal adenomas (seAFOod Polyp Prevention trial): a multicentre, randomised, double-blind, placebo-controlled, 2 × 2 factorial trial. Hull MA; Sprange K; Hepburn T; Tan W; Shafayat A; Rees CJ; Clifford G; Logan RF; Loadman PM; Williams EA; Whitham D; Montgomery AA; Lancet; 2018 Dec; 392(10164):2583-2594. PubMed ID: 30466866 [TBL] [Abstract][Full Text] [Related]
13. The efficacy of aspirin and metformin combination therapy in patients with rectal aberrant crypt foci: a double-blinded randomized controlled trial. Higurashi T; Arimoto J; Ashikari K; Takatsu T; Misawa N; Yoshihara T; Matsuura T; Fuyuki A; Ohkubo H; Nakajima A BMC Cancer; 2020 Oct; 20(1):1043. PubMed ID: 33121471 [TBL] [Abstract][Full Text] [Related]
14. Metformin for chemoprevention of metachronous colorectal adenoma or polyps in post-polypectomy patients without diabetes: a multicentre double-blind, placebo-controlled, randomised phase 3 trial. Higurashi T; Hosono K; Takahashi H; Komiya Y; Umezawa S; Sakai E; Uchiyama T; Taniguchi L; Hata Y; Uchiyama S; Hattori A; Nagase H; Kessoku T; Arimoto J; Matsuhashi N; Inayama Y; Yamanaka S; Taguri M; Nakajima A Lancet Oncol; 2016 Apr; 17(4):475-483. PubMed ID: 26947328 [TBL] [Abstract][Full Text] [Related]
15. Folic acid for the prevention of colorectal adenomas: a randomized clinical trial. Cole BF; Baron JA; Sandler RS; Haile RW; Ahnen DJ; Bresalier RS; McKeown-Eyssen G; Summers RW; Rothstein RI; Burke CA; Snover DC; Church TR; Allen JI; Robertson DJ; Beck GJ; Bond JH; Byers T; Mandel JS; Mott LA; Pearson LH; Barry EL; Rees JR; Marcon N; Saibil F; Ueland PM; Greenberg ER; JAMA; 2007 Jun; 297(21):2351-9. PubMed ID: 17551129 [TBL] [Abstract][Full Text] [Related]
16. Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies. Flossmann E; Rothwell PM; Lancet; 2007 May; 369(9573):1603-13. PubMed ID: 17499602 [TBL] [Abstract][Full Text] [Related]
17. Aspirin for the chemoprevention of colorectal adenomas: meta-analysis of the randomized trials. Cole BF; Logan RF; Halabi S; Benamouzig R; Sandler RS; Grainge MJ; Chaussade S; Baron JA J Natl Cancer Inst; 2009 Feb; 101(4):256-66. PubMed ID: 19211452 [TBL] [Abstract][Full Text] [Related]
18. Liquid chromatography-tandem mass spectrometric quantification of the dehydration product of tetranor PGE-M, the major urinary metabolite of prostaglandin E(2) in human urine. Neale JR; Dean BJ J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Aug; 871(1):72-7. PubMed ID: 18632314 [TBL] [Abstract][Full Text] [Related]
19. Chemoprevention of colorectal cancer in individuals with previous colorectal neoplasia: systematic review and network meta-analysis. Dulai PS; Singh S; Marquez E; Khera R; Prokop LJ; Limburg PJ; Gupta S; Murad MH BMJ; 2016 Dec; 355():i6188. PubMed ID: 27919915 [TBL] [Abstract][Full Text] [Related]
20. Preventive effects of low-dose aspirin on colorectal adenoma growth in patients with familial adenomatous polyposis: double-blind, randomized clinical trial. Ishikawa H; Wakabayashi K; Suzuki S; Mutoh M; Hirata K; Nakamura T; Takeyama I; Kawano A; Gondo N; Abe T; Tokudome S; Goto C; Matsuura N; Sakai T Cancer Med; 2013 Feb; 2(1):50-6. PubMed ID: 24133627 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]